AN2615: Multi-attribute quantification of LNP-mRNA therapeutics by FFF-MALS and DLS Martin Kurnik, Ph.D., Wyatt Technology, LLC Summary Introduction Bringing effective and safe lipid nanoparticle-formulated mRNA therapeutics to market requires quantitation of multiple quality attributes throughout development, manufacturing, and quality control.…
Klíčová slova
mrna, fff, spikevax, lnp, payload, mals, dls, comirnaty, lipid, size, average, dri, pdi, cumulants, regularization